Diana Hausman

2011 - Oncothyreon

In 2011, Diana Hausman earned a total compensation of $639K as Chief Medical Officer at Oncothyreon, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$79,861
Option Awards$242,000
Salary$307,750
Other$9,438
Total$639,049

Hausman received $307.8K in salary, accounting for 48% of the total pay in 2011.

Hausman also received $79.9K in non-equity incentive plan, $242K in option awards and $9.4K in other compensation.

Rankings

In 2011, Diana Hausman's compensation ranked 7,278th out of 10,747 executives tracked by ExecPay. In other words, Hausman earned more than 32.3% of executives.

ClassificationRankingPercentile
All
7,278
out of 10,747
32nd
Division
Services
1,111
out of 1,597
30th
Major group
Engineering, Accounting, Research, Management, And Related Services
115
out of 172
33rd
Industry group
Research, Development, And Testing Services
32
out of 45
29th
Industry
Commercial Physical and Biological Research
31
out of 41
24th
Source: SEC filing on April 24, 2014.

Hausman's colleagues

We found five more compensation records of executives who worked with Diana Hausman at Oncothyreon in 2011.

2011

Robert Kirkman

Oncothyreon

Chief Executive Officer

2011

Gary Christianson

Oncothyreon

Chief Operating Officer

2011

Julia Eastland

Oncothyreon

Chief Financial Officer

2011

Scott Peterson

Oncothyreon

Chief Scientific Officer

2011

Christopher Henney

Oncothyreon

Chairman

News

You may also like